The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.502
Bid: 1.502
Ask: 1.504
Change: -0.028 (-1.83%)
Spread: 0.002 (0.133%)
Open: 1.628
High: 1.628
Low: 1.478
Prev. Close: 1.53
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CIB 1Q23 Consolidated Financial Statements

15 May 2023 07:00

RNS Number : 3361Z
Commercial Intnl Bank (Egypt) SAE
14 May 2023
 

Commercial International Bank (Egypt) S.A.E.

Consolidated Financial Statements

 

March 31, 2023

Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/3361Z_1-2023-5-14.pdf

 

 

 

Condensed Consolidated Interim Statement of Financial Position as at March 31, 2023

 

Notes

Mar. 31, 2023

 

Dec. 31, 2022

 

EGP Thousands

 

EGP Thousands

 

Assets

 

 

 

 

Cash and balances at the central bank

8

52,462,528

 

47,492,549

 

Due from banks

9

170,682,323

 

133,856,720

 

Loans and advances to banks, net

11

616,088

 

2,978,197

 

Loans and advances to customers, net

12

213,047,067

 

193,599,872

 

Derivative financial instruments

 

2,088,501

 

1,939,961

 

Investments

 

 

 

- Financial Assets at Fair Value through OCI

13

185,998,930

 

204,020,733

 

- Financial Assets at Amortized cost

13

43,654,330

 

34,524,760

 

- Investments in associates

14

157,091

 

186,062

 

Non current assets held for sale

29

220,335

 

-

 

Other assets

15

14,774,256

 

14,521,427

 

Goodwill

26

85,954

 

96,268

 

Intangible assets

27

21,597

 

24,188

 

Deferred tax assets

 

-

 

185,746

 

Property and equipment

16

2,478,113

 

2,405,434

 

Total assets

 

686,287,113

 

635,831,917

 

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

17

8,286,885

 

3,496,698

 

Due to customers

18

576,828,746

 

531,616,550

 

Non current liabilities held for sale

30

890

 

-

 

Derivative financial instruments

 

8,294

 

219,752

 

Deferred tax liabilities

65,046

 

-

 

Current income tax liabilities

1,991,935

 

3,051,583

 

Other liabilities

19

16,078,448

 

11,606,912

 

Issued debt instruments

20

3,069,231

 

2,456,607

 

Other loans

 

9,586,379

 

7,978,975

 

Other provisions

21

8,700,532

 

7,066,672

 

Total liabilities

 

624,616,386

 

567,493,749

 

Equity

 

 

 

 

Issued and paid up capital

 

29,990,563

 

29,825,134

 

Reserves

 

23,559,843

 

19,643,327

 

Reserve for employee stock ownership plan (ESOP)

1,667,377

 

1,895,435

 

Retained earnings *

6,330,323

16,393,841

Total equity and net profit for the period / year

 

61,548,106

 

67,757,737

 

Non Controlling Interest

122,621

580,431

 

Total minority interest, equity and net profit for the period / year

61,670,727

68,338,168

 

Total liabilities and equity

 

686,287,113

 

635,831,917

 

 

 

 

The accompanying notes are an integral part of these financial statements .

 

 

(Limited review report attached)

* Including net profit for the current period

 

 

 

 

 

 

 

Hussein Abaza

Hisham Ezz Al-Arab

 

CEO & Managing Director

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Income Statement for the period ended March 31, 2023

 

 

 

 

 

Notes

 

 

Mar. 31, 2023

 

Mar. 31, 2022

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Interest and similar income

19,823,554

 

12,006,043

 

Interest and similar expense

(8,939,377)

 

(5,288,771)

 

Net interest income

 

10,884,177

 

6,717,272

 

 

 

 

 

 

Fee and commission income

2,005,304

 

1,203,252

 

Fee and commission expense

(792,175)

 

(515,125)

 

Net fee and commission income

 

1,213,129

 

688,127

 

 

 

 

 

 

Dividend income

 

32,362

 

37,800

 

Net trading income

5

 

1,851,908

 

732,821

 

Profits (Losses) on financial investments

13

 

70,920

 

1,040,297

 

Administrative expenses

 

(2,063,690)

 

(1,670,887)

 

Other operating (expenses) income

6

(2,040,922)

 

(1,431,967)

 

Goodwill amortization

26

 

(10,314)

 

(10,314)

 

Intangible assets amortization

27

 

(2,591)

 

(2,591)

 

Impairment release (charges) for credit losses

 

(944,829)

 

38,692

 

Bank's share in the profits / losses of associates

(14,871)

 

2,841

 

Profit before income tax

8,975,279

 

6,142,091

 

 

 

 

 

Income tax expense

28

(2,262,132)

 

(1,372,939)

 

Deferred tax assets (Liabilities)

28

(645,223)

 

(509,534)

 

Net profit from continued operations

 

6,067,924

 

4,259,618

 

 

 

 

 

Discontinued Operations

 

 

 

Net profit from discontinued operations

31

870

 

-

 

Net profit for the period

 

 

6,068,794

 

4,259,618

 

 

 

 

 

 

Non Controlling Interest

3,847

 

15,387

 

 

Bank's shareholders

6,064,947

 

4,244,231

 

Earning per share

7

 

 

 

 

Basic

1.81

 

1.26

 

Diluted

1.79

 

1.24

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

Hisham Ezz Al-Arab

CEO & Managing Director

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of Comprehensive Income for the period ended March 31, 2023

 

Mar. 31, 2023

 

Mar. 31, 2022

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

Net profit for the period

 

6,068,794

 

4,259,618

 

Change in fair value of Financial investments measured at fair value through comprehensive income after tax

(8,522,293)

 

(3,961,167)

 

Transferred to RE from financial assets at fair value through comprehensive income

(1,895)

 

(4,201)

 

Cumulative foreign currencies translation differences

281,927

 

52,636

 

Effect of ECL in fair value of debt instruments measured at fair value through comprehensive income

208,752

 

101,602

 

Total comprehensive income for the period

(1,964,715)

 

448,488

 

 

 

 

 

 

 

 

As follows:

 

Bank's shareholders

(1,968,562)

433,101

 

Non Controlling Interest

3,847

15,387

 

Total comprehensive income for the period

(1,964,715)

448,488

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended March 31 2023

 

 

Notes

Mar. 31, 2023

 

Mar. 31, 2022

EGP Thousands

 

EGP Thousands

 

 

Cash flow from operating activities

 

 

Profit before income tax from continued operations

8,975,279

 

6,142,091

Profit from discontinued operations

870

 

-

Adjustments to reconcile profits to net cash provided by operating activities

 

 

 

Fixed assets depreciation

16

228,065

 

223,781

Impairment (Released) charge for credit losses (Loans and advances to customers and banks)

 

707,740

 

(145,266)

Other provisions charges

21

464,311

 

1,036,252

Impairment (Released) charge for credit losses (due from banks)

 

2,096

 

4,776

Impairment (Released) charge for credit losses (financial investments)

234,993

 

101,798

Impairment (Released) charge for other assets

-

 

(277,768)

Exchange revaluation differences for financial assets at fair value through OCI and AC

(6,033,831)

 

63

Goodwill amortization

26

10,314

 

10,314

Intangible assets amortization

27

2,591

 

2,591

Utilization of other provisions

21

(345)

 

(156)

Other provisions no longer used

21

-

 

(385)

Exchange differences of other provisions

21

1,169,894

 

278,463

profits from selling property and equipment

 

(118)

 

(50)

profits from selling financial investments at fair value through OCI

13

(70,920)

 

(1,040,297)

Shares based payments

 

190,974

 

175,235

Bank's share in the profits / losses of associates

14,871

 

(2,841)

Operating profits before changes in operating assets and liabilities

5,896,784

 

6,508,601

 

 

 

Net decrease (increase) in assets and liabilities

 

 

Due from banks

 

12,110,117

 

25,468,271

Financial assets at fair value through P&L

 

-

 

239,339

Derivative financial instruments

 

(359,998)

 

(680,085)

Loans and advances to banks and customers

11 - 12

(17,792,410)

 

(12,821,977)

Other assets

 

(96,139)

 

1,844,416

Non current assets held for sale

(220,335)

 

-

Due to banks

17

4,790,187

 

2,859,939

Due to customers

18

45,212,196

 

21,780,515

Current income tax obligations paid

 

(270,197)

 

(259,516)

Non current liabilities held for sale

 

890

 

-

Other liabilities

 

(354,332)

 

1,860,904

Net cash generated from (used in) operating activities

 

48,916,763

 

46,800,407

 

 

 

Cash flow from investing activities

 

 

Payment for purchases of property, equipment and branches constructions

(457,850)

 

(92,999)

Proceeds from selling property and equipment

118

 

50

Proceeds from redemption of financial assets at amortized cost

 

196,783

 

2,609,283

Payment for purchases of financial assets at amortized cost

(8,533,818)

 

(2,474,553)

Payment for purchases of financial assets at fair value through OCI

(32,339,905)

 

(68,625,535)

Proceeds from selling financial assets at fair value through OCI

46,767,421

 

78,456,150

Payment for investment in subsidiaries.

(1,008,761)

 

-

Net cash generated from (used in) investing activities

4,623,988

 

9,872,396

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended March 31, 2023 (Cont.)

 

 

Mar. 31, 2023

 

Mar. 31, 2022

EGP Thousands

 

EGP Thousands

 

 

Cash flow from financing activities

 

 

Other loans

 

1,607,404

 

1,035,994

Dividends paid

 

(1,988,585)

 

(4,410,322)

Issued debt instruments

612,624

 

253,338

Capital increase

165,429

 

122,716

Net cash generated from (used in) financing activities

396,872

 

(2,998,274)

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

53,937,623

 

53,674,529

Beginning balance of cash and cash equivalent

92,969,526

 

61,065,822

Cash and cash equivalent at the end of the period

146,907,149

 

114,740,351

 

 

 

 

Cash and cash equivalent comprise:

 

 

Cash and balances at the central bank

 

52,462,528

 

30,581,505

Due from banks

 

170,733,811

 

121,128,084

Treasury bills and other governmental notes

10 

68,681,151

 

40,379,000

Obligatory reserve balance with CBE

 

(46,005,523)

 

(26,188,639)

Due from banks with maturities more than three months

(29,664,721)

 

(10,245,456)

Treasury bills with maturity more than three months

(69,300,097)

 

(40,914,143)

Total cash and cash equivalent

146,907,149

 

114,740,351

'

 

 

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2022

 

Mar. 31, 2022

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

EGP Thousands

Beginning balance

19,702,418

3,293,074

28,260,532

1,550,906

8,183

16,000

641,372

9,141

13,696,402

1,674,392

(4,218)

68,848,202

454,535

69,302,737

Capital increase

122,716

-

502,922

-

-

-

-

-

-

(502,922)

-

122,716

-

122,716

Transferred to reserves

-

670,872

8,333,404

-

-

2,947

-

-

(9,007,223)

-

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(4,410,322)

-

-

(4,410,322)

-

(4,410,322)

Net profit of the period

-

-

-

-

-

-

-

-

4,244,231

-

-

4,244,231

15,387

4,259,618

 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(4,201)

-

4,201

-

-

-

-

-

Net unrealized gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(3,961,167)

-

-

-

-

(3,961,167)

-

(3,961,167)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

2,840

(2,840)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

101,602

-

-

-

-

101,602

-

101,602

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

175,235

-

175,235

-

175,235

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

56,854

56,854

39,279

96,133

Balance at the end of the period

19,825,134

3,963,946

37,096,858

1,550,906

8,183

18,947

(3,222,394)

11,981

4,524,449

1,346,705

52,636

65,177,351

509,201

65,686,552

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2023

 

 

 

 

Mar. 31, 2023

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

 

EGP Thousands

Beginning balance

29,825,134

3,963,946

27,096,858

1,550,906

8,183

18,947

(13,188,818)

11,981

16,393,841

1,895,435

181,324

67,757,737

580,431

68,338,168

Capital increase

165,429

-

-

-

-

-

-

-

-

-

-

165,429

-

165,429

Transferred to reserves

-

806,408

11,998,639

-

-

2,208

-

-

(12,388,223)

(419,032)

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(3,738,888)

-

-

(3,738,888)

(23,982)

(3,762,870)

Net profit of the period

-

-

-

-

-

-

-

-

6,064,947

-

-

6,064,947

3,847

6,068,794

 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(1,895)

-

1,895

-

-

-

-

-

Change in non controlling interest from acquisition of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

(536,867)

(536,867)

Reserve for transactions under common control

-

-

-

-

(679,155)

-

-

-

-

-

-

(679,155)

-

(679,155)

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(8,522,293)

-

-

-

-

(8,522,293)

-

(8,522,293)

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

3,249

(3,249)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

208,752

-

-

-

-

208,752

-

208,752

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

190,974

-

190,974

-

190,974

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

100,603

100,603

99,192

199,795

 

Balance at the end of the period

 

29,990,563

4,770,354

39,095,497

1,550,906

(670,972)

21,155

(21,504,254)

15,230

6,330,323

1,667,377

281,927

61,548,106

122,621

61,670,727

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFNKQBKABKDBPD
Date   Source Headline
22nd Feb 20227:00 amRNSCIB FY 2021 Consolidated Financial Results
22nd Feb 20227:00 amRNSCIB FY2021 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Separate Condensed Financial Results
12th Nov 20217:00 amRNSCIB 3Q21 Earnings Release
12th Nov 20217:00 amRNSCIB 3Q21 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB1H2021 Earnings Release
13th Jul 20217:00 amRNSCIB1H2021 Condensed Consolidated Financial Results
13th Jul 20217:00 amRNSCIB 1H2021 Condensed Separate Financial Results
24th Jun 20213:43 pmRNSRelease re the change of title of Mr.Hussein Abaza
24th May 20217:00 amRNSCIB 1Q2021 Earnings Release
24th May 20217:00 amRNSCIB 1st Quarter Consolidated Financial Results
24th May 20217:00 amRNSCIB 1st Quarter Separate Financial Results
29th Apr 202110:09 amRNSCIB FY2020 Annual Financial Report
31st Mar 20215:28 pmRNSResolutions of CIB ordinary GAM held on March 30
8th Mar 20218:24 amRNSInvitation to CIB OrdinaryGeneral Assembly Meeting
8th Mar 20217:00 amRNSRelease regarding a change in CIB's BOD Structure
1st Mar 20217:00 amRNSCIB FY20 Year End Earnings Release
1st Mar 20217:00 amRNSCIB FY20 Year End Separate Financial Results
1st Mar 20217:00 amRNSCIB FY20 Consolidated Results
16th Dec 20207:00 amRNSCIB 3Q20 Earnings Release
16th Dec 20207:00 amRNSCIB 3rd Quarter Consolidated Condensed Results
16th Dec 20207:00 amRNSCIB 3rd Quarter Separate Condensed Results
16th Nov 20207:00 amRNSCIB Release on November 15th,2020
27th Oct 20202:28 pmRNSCIB's Press Release dated October 27th, 2020
23rd Oct 20203:59 pmRNSCIB Press Release
12th Oct 20204:13 pmRNSRelease concerning changes in CIB'sBoard Structure
22nd Sep 20202:33 pmRNSRelease on change in Board of Directors Structure
15th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Jul 20207:00 amRNSCIB First Half 2020 Earnings Release
14th Jul 20207:00 amRNSCIB Consolidated Interim Condensed June Statements
14th Jul 20207:00 amRNSCIB Interim Separate Condensed June Statements
1st Jul 20201:04 pmRNSRelease on Subordinated debt from CDC
5th May 20207:00 amRNSCIB reports 1Q20 Earning Release
5th May 20207:00 amRNSCIB 1st Quarter Consolidated Results
5th May 20207:00 amRNSCIB 1st Quarter Separate Results
28th Apr 20207:00 amRNSCIB Year End 2019 IFRS Consolidated Results
27th Apr 20207:00 amRNSCIB acquires 51% of Mayfair Bank in Kenya
30th Mar 20209:00 amRNSRelease on CEO self-quarantine
24th Mar 202012:02 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSCIB's AGM Resolutions (March 15th 2020)
16th Mar 20207:00 amRNSCIB's EGM Resolutions (March 15th 2020)
20th Feb 20202:39 pmRNSItems to be discussed in EGM of March 15th, 2020
20th Feb 20202:37 pmRNSItems to be discussed in AGM of March 15th, 2020
18th Feb 20202:31 pmRNSInvitation to CIB Extraordinary GAM
18th Feb 20202:29 pmRNSInvitation toCIB Ordinary General Assembly Meeting
4th Feb 20207:00 amRNSFY 2019 Separate Financial Results
4th Feb 20207:00 amRNSFY 2019 Consolidated Financial Results
4th Feb 20207:00 amRNSFY 2019 Earnings Release
5th Nov 20197:00 amRNSCIB 3Q 2019 Consolidated Financial Results
5th Nov 20197:00 amRNSCIB Separate 3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.